Atrial fibrillation monitoring to reduce thromboembolic risk: Selecting the patient and the monitoring device
Key result
Continuous monitoring with ICMs detects silent AF in ~20% of cryptogenic stroke patients.
Why the study?
The silent and intermittent nature of atrial fibrillation complicates identification of patients at risk of thromboembolism, highlighting the importance of effective AF monitoring.
Population
Patients at risk of atrial fibrillation including those with cryptogenic stroke
Comparison
Atrial fibrillation monitoring using implantable cardiac monitors versus no or less intensive monitoring
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May support prolonged monitoring in high-risk patients; leaves open optimal anticoagulation thresholds for device-detected subclinical episodes.
Structured PICO
P
Population
Patients at risk of atrial fibrillation, including those with cryptogenic stroke
E
Exposure
Atrial fibrillation monitoring (e.g., continuous monitoring with implantable cardiac monitors)
Continuous monitoring for atrial fibrillation is crucial for identifying silent AF and guiding antithrombotic therapy to reduce thromboembolic risk, especially in patients with cryptogenic stroke.
Cite This Study
Barra et al. (2017) conducted a review in Atrial fibrillation. Atrial fibrillation monitoring was evaluated. Continuous monitoring with implantable cardiac monitors identifies silent atrial fibrillation in approximately 20% of patients with cryptogenic stroke.